Overview
- The joint statement, released Friday by Leopoldina, Acatech and the Union of the German Academies, outlines a two-stage plan that screens people with low-cost digital tools before moving high-risk groups to brain scans or spinal fluid tests.
- The proposal would build individual risk profiles that combine lifestyle and medical factors with DNA markers such as ApoE‑ɛ4, which can raise the chance of late-onset Alzheimer’s many times over and may guide new antibody treatments.
- Backers point to real-world data gains, citing records from Wales that linked shingles vaccination in older adults with lower dementia rates, which they say helps turn large datasets into practical advice like vaccine guidance.
- Implementation still faces hurdles in Germany, since insurers are not allowed to target people with prevention offers based on personal data and health records from clinics, registries and apps must be linked and stored with strong legal safeguards.
- The push comes as Germany counts about 1.8 million people with dementia and projects roughly 2.7 million by 2050, while modeling studies suggest that cutting known risks could prevent about 40 to 45 percent of cases and the authors call for a decade of brain health to test what works.